These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

270 related articles for article (PubMed ID: 15308510)

  • 1. A new era in the management of pulmonary arterial hypertension related to scleroderma: endothelin receptor antagonism.
    Hachulla E; Coghlan JG
    Ann Rheum Dis; 2004 Sep; 63(9):1009-14. PubMed ID: 15308510
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [PAH and many other indications. Old and new endothelin receptor antagonists.].
    Schmitz J; Holzgrabe U
    Pharm Unserer Zeit; 2010 Nov; 39(6):430-5. PubMed ID: 20967930
    [No Abstract]   [Full Text] [Related]  

  • 3. Bosentan therapy for pulmonary arterial hypertension.
    Rubin LJ; Badesch DB; Barst RJ; Galie N; Black CM; Keogh A; Pulido T; Frost A; Roux S; Leconte I; Landzberg M; Simonneau G
    N Engl J Med; 2002 Mar; 346(12):896-903. PubMed ID: 11907289
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Endothelin and endothelin receptor antagonists in systemic rheumatic disease.
    Mayes MD
    Arthritis Rheum; 2003 May; 48(5):1190-9. PubMed ID: 12746891
    [No Abstract]   [Full Text] [Related]  

  • 5. Bosentan increases serum IL-12 levels in systemic sclerosis patients with pulmonary arterial hypertension.
    Hamaguchi Y; Fujimoto M; Hasegawa M; Matsushita T; Takehara K
    J Dermatol Sci; 2009 Jul; 55(1):66-7. PubMed ID: 19342201
    [No Abstract]   [Full Text] [Related]  

  • 6. Bosentan for the treatment of adult pulmonary hypertension.
    Dwyer N; Kilpatrick D
    Future Cardiol; 2011 Jan; 7(1):19-37. PubMed ID: 21174507
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Endothelin].
    Maeda S; Miyauchi T; Goto K
    Nihon Rinsho; 2006 Jul; 64 Suppl 5():112-6. PubMed ID: 16895176
    [No Abstract]   [Full Text] [Related]  

  • 8. Endothelin receptor antagonists for pulmonary arterial hypertension: an overview.
    Raja SG
    Cardiovasc Ther; 2010 Oct; 28(5):e65-71. PubMed ID: 20406243
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bosentan.
    Mathier MA; Ishizawar D
    Expert Opin Pharmacother; 2010 Apr; 11(6):1023-34. PubMed ID: 20307226
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dual endothelin receptor antagonism in pulmonary arterial hypertension.
    Pittrow D; Kirch W
    Eur J Clin Invest; 2006 Sep; 36 Suppl 3():v-vi. PubMed ID: 16919003
    [No Abstract]   [Full Text] [Related]  

  • 11. Secondary pulmonary arterial hypertension: treated with endothelin receptor blockade.
    Sharma S; Kashour T; Philipp R
    Tex Heart Inst J; 2005; 32(3):405-10. PubMed ID: 16392231
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Survival in patients with pulmonary arterial hypertension treated with first-line bosentan.
    McLaughlin VV
    Eur J Clin Invest; 2006 Sep; 36 Suppl 3():10-5. PubMed ID: 16919005
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Bosentan treatment for pulmonary arterial hypertension related to connective tissue disease: a subgroup analysis of the pivotal clinical trials and their open-label extensions.
    Denton CP; Humbert M; Rubin L; Black CM
    Ann Rheum Dis; 2006 Oct; 65(10):1336-40. PubMed ID: 16793845
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Endothelin receptor antagonists as disease modifiers in systemic sclerosis.
    Shetty N; Derk CT
    Inflamm Allergy Drug Targets; 2011 Feb; 10(1):19-26. PubMed ID: 21184655
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pulmonary arterial hypertension in connective tissue diseases.
    Goldberg A
    Cardiol Rev; 2010; 18(2):85-8. PubMed ID: 20160534
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Endothelin receptor antagonists -- their role in pulmonary medicine.
    Boniface S; Reynaud-Gaubert M
    Rev Mal Respir; 2011 Oct; 28(8):e94-e107. PubMed ID: 22099418
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Role of endothelin receptor antagonists in the treatment of pulmonary arterial hypertension.
    Abman SH
    Annu Rev Med; 2009; 60():13-23. PubMed ID: 18764741
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Therapy according to current guidelines. Practical management of pulmonary arterial hypertension.].
    Pabst S; Hammerstingl C; Nickenig G; Skowasch D
    Pharm Unserer Zeit; 2010 Nov; 39(6):448-52. PubMed ID: 20967933
    [No Abstract]   [Full Text] [Related]  

  • 19. Addition of sildenafil to bosentan monotherapy in pulmonary arterial hypertension.
    Mathai SC; Girgis RE; Fisher MR; Champion HC; Housten-Harris T; Zaiman A; Hassoun PM
    Eur Respir J; 2007 Mar; 29(3):469-75. PubMed ID: 17079256
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Pulmonary arterial hypertension related to systemic sclerosis in 2008].
    Agard C; Haloun A; Hamidou MA
    J Mal Vasc; 2009 Feb; 34(1):7-15. PubMed ID: 19081217
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.